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KETEPATAN DOSIMETRI AND GEOMETRI UNTUK RADIOTERAPI 
MODULASI KEMATAN-BERPANDUKAN IMEJ (IG-IMRT) BAGI 
PESAKIT TUMOR KEPALA DAN LEHER 
 
 
ABSTRAK 
 
Kemajuan dalam teknologi radioterapi telah membolehkan radioterapi 
modulasi kematan (IMRT) untuk merawat pesakit dengan ketepatan kedudukan 
pesakit yang lebih baik menggunakan radioterapi berpandukan imej (IGRT). Kajian 
ini menyiasat ketepatan IG-IMRT merawat 25 pesakit kanser kepala dan leher (HNC) 
di Institut Perubatan dan Pergigian Termaju (IPPT), Universiti Sains Malaysia. Sebuah 
detektor susun-atur kebuk ion telah dipercirikan dan digunakan untuk verifikasi pelan 
rawatan IMRT. Kajian percirian menunjukkan dos yang diukur meggunakan detektor 
susun-atur kebuk ion mempunyai perbezaan <2% dengan dos yang dikira dari sistem 
perancangan rawatan (TPS). Semua 25 pelan pesakit IMRT mencatatkan kadar 
peratusan lulus ≥95% apabila kriteria gama 3%/3 mm digunakan.  Sebanyak 231 
CBCT imej telah diperolehi selepas persediaan pesakit sebelum rawatan IMRT 
dimulakan. Margin PTV  ≥3 mm diperlukan dalam arah RL, SI dan AP  jika tiada 
pembetulan persediaan dilakukan. Protokol NAL dan eNAL disimulasikan dalam ralat 
persediaan. Protokol eNAL merekodkan ralat persediaan yang terkecil dalam kesemua 
tiga arah yang dikaji iaitu 1.59 mm untuk RL, 2.13 mm untuk SI dan 1.61 mm untuk 
AP. Kesan ralat persediaan pada dos pengagihan juga dinilai pada 6 pesakit HNC 
terpilih. Penggunaan protokol eNAL berupaya meningkatkan peratus kawasan  
menerima sekurang-kurang 95% daripada dos yang ditetapkan sebanyak 0.12%, 
0.15% dan 0.80% untuk CTV1, CTV2 dan CTV3 berbanding peta dos tanpa 
pembetulan ralat kedudukan pesakit.  
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DOSIMETRIC AND GEOMETRIC ACCURACY OF IMAGE GUIDED 
INTENSITY MODULATED RADIOTHERAPY (IG-IMRT) IN HEAD AND 
NECK CANCER PATIENTS 
 
 
ABSTRACT 
 
Advances in radiotherapy technology has made it possible to deliver highly 
conformal Intensity Modulated Radiotherapy (IMRT) beam to treat patient with 
improved setup accuracy using Image Guided Radiotherapy (IGRT). This 
retrospective study investigates the accuracy of IG-IMRT treatment for 25 head and 
neck cancer (HNC) patients in Advanced Medical & Dental Institute (AMDI), 
Universiti Sains Malaysia. An ionisation chamber array detector has been 
characterised and used for patient specific IMRT QA. The characterisation study 
shows the doses measured using ionisation chamber array detector were within 2% 
compared with the doses calculated from the treatment planning system (TPS). All 25 
IMRT treatment obtained percentage pass rate ≥95% when 3%/3 mm gamma criteria 
were used.  The geometrical accuracy of the treatment was also analysed based on 
setup errors measured using kV cone beam CT based-IGRT. A total of 231 pre-
treatment CBCT imaging were acquired prior to treatment and compared to the 
reference CT. PTV margin of  ≥3 mm in RL direction, SI direction and AP direction 
is required if no setup correction was performed. Offline setup protocols; NAL and 
eNAL were simulated on the setup errors recorded. The eNAL protocol recorded the 
smallest setup error in all three directions; which were 1.59 mm for RL direction, 2.13 
mm for SI direction and 1.61 mm for AP direction. The impact of setup errors on dose 
distributions was also assessed on six HNC patients. The eNAL protocol improved 
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target coverage with 0.12%, 0.15% and 0.80% higher volume of CTV1, CTV2 and 
CTV3 region, respectively receiving at least 95% of prescribed dose compared to 
without setup error correction. Therefore, setup error correction is important to ensure 
the precise delivery of radiotherapy treatment by reducing both systematic and random 
errors which resulted a better coverage of tumour volume to be irradiated.  In 
conclusion, CBCT-based IGRT correction technique is an effective method to further 
improve the accuracy of IMRT treatment in HNC patient.
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CHAPTER 1 INTRODUCTION 
 
 
1.1 Introduction to radiotherapy 
 
Cancer has become one of the most common diseases in the world according to World 
Health Organisation (WHO). Death worldwide caused by cancer is 8.8 million in 2015 
[1]. According to the latest National Cancer Registry of Malaysia (NCR), a total 
number of 103,507 new cancer cases were diagnosed in Malaysia during the period of 
2007 to 2011 [2]. The incidence of new cases is increasing which may be attributed to 
increase in general life expectancy, change in dietary intake and lifestyle, 
improvements in diagnostics technology for early detection and also increased access 
to healthcare system from rural areas [3,4]. 
With ever increasing number and complexity of cancer cases, radiotherapy has 
become one of the important treatment modalities in treating cancer. Radiotherapy 
treatment is delivered either as a standalone treatment or in combination with 
chemotherapy and/or surgery. The main objective of radiotherapy treatment is to 
accurately deliver radiation dose to the tumour target in order to destroy cancer cells 
and at the same time minimising the radiation dose to normal tissues surrounding the 
tumour. Radiation may be delivered from radioactive source internally dwelled into 
the body which is known as brachytherapy or externally using machine to delivered 
radiation to penetrate the body known as external beam radiotherapy (EBRT). EBRT 
is the focus of the work and will be referred to as radiotherapy throughout the thesis. 
Radiotherapy can either be intended for curative to cure the patient from cancer, or as 
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an adjunct to other modalities to increase rates of cure and remission from cancer or 
as a palliative modality to symptomatically relief symptoms such as pain or bleeding.  
1.1.1 Radiotherapy linear accelerator 
 
Radiotherapy uses a linear accelerator (linac) to generate high energy x-rays and 
electrons to conform to the planned target while sparing surrounding normal tissues. 
A linac consists of a rotating gantry head and treatment couch as shown in Figure 1.1. 
Modern linac also has a kV x-ray unit located at the left arm of the linac and a detector, 
located at the right arm of the linac. The kV x-ray unit is also known as cone-beam 
computed tomography (CBCT). It provides a high-quality verification image at the 
treatment site. The technique is called image guided radiation therapy (IGRT). This 
will further be discussed in section 1.3.  
High energy x-ray photons are generated from the gantry head of linac is 
showed in Figure 1.2. Electrons are generated from the heating of filament within the 
electron gun (cathode). The electrons are then injected to the tube structure called the 
accelerator waveguide and accelerates along it with almost the speed of light.  The 
electron beam then enters a flight tube which contains bending magnet. The bending 
magnet will direct the electron beam towards the target. The electron beams 
accelerated and its kinetic energy increased until it collides with the target. The 
interaction produces Bremsstrahlung x-ray photons.  
Some of the high energy photons which emerge from the target pass through a 
primary collimator of the linac. A beam flattening flatter is placed in the path of 
photons to absorb more forward peaking photons than the ones in periphery. The filter 
helps in shaping the photon beams in its cross-sectional dimensions to a more uniform 
beam.  
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Two ionisation chambers are located below the flattening filter to monitor 
integrated dose, dose rate and also field symmetry. The radiation beams that leave the 
x-ray target or the flattening filter will pass through the dual monitor ionisation 
chambers and produce the ionisation current. Once the photon beam passed the dual 
monitor ionisation chamber, the beam is shaped using a secondary collimator. The 
secondary collimator helps to deliver a beam that is more conformal to the tumour. 
The conventional beam shaping uses the combination of upper jaw and lower jaw and 
also beam blocks which attached to the accelerator to produce a rectangular or square 
field. However, this conventional method restricts the conformity of the beam as it 
only allows limited number of beam shape.  The multileaf collimators (MLC) is used 
for a more flexible beam shaping system.  They are heavy metal field-shaping device 
with independent moving mechanism that direct the radiation dose to the tumour. The 
MLCs are the key element in the treatment delivery of x-ray beams with intensity 
modulated radiotherapy (IMRT) which will be discuss further in section 1.2.  
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Figure 1.1: Linear accelerator from Elekta (Picture courtesy from 
www.oncologysystems.com) 
 
 
Figure 1.2: Schematic diagram of gantry head of lina 
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1.1.2 Radiotherapy treatment flow  
 
Modern conformal radiotherapy has evolved from using bony anatomy as surface 
landmarks for hand-drawn blocking towards specialised planning that incorporates 
three-dimensional (3D) reconstructed images with computer optimisation algorithms 
for dose calculation. The conventional radiotherapy treatment of two-dimensional 
(2D) radiotherapy contains a single beam. The beam setups for conventional 
radiotherapy are quite simple because the plans are either consisted of opposed lateral 
fields or four field “boxes” [5]. Three-dimensional conformal radiotherapy (3D-CRT) 
and IMRT are more conformal radiotherapy treatment compared to 2D radiotherapy 
as they use collimators on linac to deliver accurate radiation doses to the target volume.  
However, compared to IMRT, 3D-CRT treatment planning system is manually 
optimised [6]. This means that the treatment planners have to decide all the beam 
parameters, such as the number of beams, beam directions, shapes, wedges and 
weightages for to obtain the desired dose distribution. After all the parameters have 
been set, only then the computer calculates the resulting dose distribution. Conversely, 
for IMRT treatment, the physicist only has to decide the desired dose distributions and 
some of the treatment parameters. The rest of the treatment parameters are calculated 
by the computerised treatment planning system.  
There are several stages of process in radiotherapy treatment. When a patient 
is planned for radiotherapy, a computerised planning needs to be done to ensure precise 
dose is delivered to the target volume and sparing the critical structures near target 
volume. The patient is positioned in a comfortable reproducible position and this may 
require using immobilisation device such as thermoplastic mask to maintain position. 
Then, the images of the tumour position are acquired using computed tomography 
(CT) scanner for target delineation. Advanced imaging modalities such as Magnetic 
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Resonance Imaging (MRI), Positron Emission Tomography (PET) or PET/CT are used 
for more precise target delineation and better sparing of organ at risk (OAR). All 
images are then sent to a treatment planning system (TPS). Image fusion of different 
imaging modalities can also be done to ensure a more accurate and precise target 
delineation for the purpose of planning radiotherapy treatment.   
Treatment planners consisted of oncologist and physicist will work together to 
contour the tumour region that need to be treated as well as OAR surrounding the 
tumour to be spared on the TPS. The oncologist delineates the structures of the target 
volumes and OARs on the images obtained from a CT scan or fused and registered 
with other imaging modalities. Thus, the main volumes to be considered while 
contouring are the gross tumour volume (GTV); a contour on gross radiologically 
visible tumour, the clinical target volume (CTV); tissues surrounding GTV that 
pathologically at high risk to contain subclinical malignant diseases and planning 
target volume (PTV); a geometric extension of CTV to account for setup errors during 
treatment and in between treatment motion. These tumour volumes are shown in 
Figure 1.3. The OARs are normal tissues surrounding the target volume that may 
receive unwanted radiation doses during treatment.  These tumour delineation follows 
the recommendation by the International Commission on Radiation Unit and 
Measurements 62 (ICRU 62) [7].   
After delineation process, the physicist needs to specify number of gantry 
angles and dose goals for target dose and OARs objectives in the inverse planning 
system. Normally, a physicist or a dosimetrist will set a constraint to the critical 
structures surrounding the target in order to instruct the TPS to consider keeping the 
dose of those regions low when planning the beams.  This helps to guide optimisation 
process of IMRT planning which will take place once all doses have been prescribed 
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to contoured structures. The TPS dose calculation algorithms that can be used are 
Monte Carlo algorithm and pencil beam algorithm. The dose calculated will then be 
evaluated to ensure the treatment prescription is either achieved or not and the OAR 
dose limits are satisfied. A dose-volume histogram (DVH) will then be generated from 
TPS as a plan evaluation tool by the planner to evaluate doses to different structures. 
DVH is a histogram of radiation dose to tissue volume in radiotherapy treatment 
planning. It summarises the 3D dose distribution in a graphical 2D format. The 
"volumes" referred to in DVH analysis are the tumour target, OARs surrounding the 
target, or an arbitrary structure. This is to ensure that the planned treatment beam and 
dose prescription are able to cover the target volume and at the same time the organ at 
risks surrounding the target are spared. 
Finally, once the dose distributions and DVHs have been reviewed by physicist 
and approved by oncologist, the treatment plan needs to be verified by modelling the 
treatment planned into a dosimeter and carry out the patient specific IMRT quality 
assurance (QA) which will be discussed further in section 1.2.1.  
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Figure 1.3: Schematic diagram of target delineation recommended by ICRU 62 
 
 
Figure 1.4: Example of CT image of head and neck cancer captured from Monaco 
TPS in AMDI, USM 
 
The dosimetric accuracy is one of the radiotherapy challenges. The dosimetric 
inaccuracy may affect the treatment verification. There are several causes of 
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dosimetric inaccuracy such as linac delivery, dose calculation error and dosimeter error 
[8,9]. However, the factor of dosimetric inaccuracy that will be focussed in this study 
is the dosimeter error. If the dosimeter used for treatment verification lack of good 
characteristics such as linearity and directional dependence, the precision and accuracy 
of treatment verification may also be affected.  The discussion on dosimetric accuracy 
will further be discussed under section 1.2.1 and 1.2.2.  
Geometrical accuracy is also one of the challenges in radiotherapy.  The 
geometrical accuracy may affect the patient setup which will then result in higher dose 
to organ at risks and lower dose to tumour target.  Deviations in patient setup and organ 
motion are often become the limiting aspects to achieve the precision and accuracy of 
radiation delivery in IMRT [10]. The errors might arise due to immobilisation and 
setup uncertainty during patient positioning. Further discussion on the effect of 
geometrical accuracy will be discussed in section 1.3.   
 
1.2 Intensity Modulated Radiotherapy (IMRT)  
 
IMRT is one of the advanced forms of radiotherapy treatments. IMRT uses collimators 
which is known as multi-leaf collimator (MLC) as shown in Figure 1.5 to deliver a 
conformal radiation dose. MLC has replaced the beam blocks in conventional method 
of field shaping. MLC consists of movable leaves arranged in two opposing rows.  
Step-and-shoot MLC can move in immobile position during beam off whereby 
dynamic MLC move continuously while the beam is on [11]. The movement of the 
MLC leaves help to generate a more complex beam shape to modify the beam intensity 
for IMRT treatment. The enhancement of the beam shaping technique ensures an 
efficient delivery of complex beam during IMRT treatment.  
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Figure 1.5 Example of multileaf collimator (Figure courtesy from Varian Medical 
System, www.varianmediaroom.com) 
 
Several recent studies have demonstrated how IMRT can improve dose to 
target tissues while sparing the surrounding normal tissues [12,13] . A study on IMRT 
dose sparing shows that xerostomia can be successfully prevented or reduced by 
restricting the maximum mean dose threshold to 26 Gy for at least one parotid gland 
[14]. Even though IMRT improves dose distributions to the targets organs and decrease 
irradiation doses to normal tissue, the high conformality may also result in 
geographical misses and locoregional failures.  Therefore, there is a need of proper 
delineation of tumour and sparing OARs [13]. 
1.2.1 Patient specific IMRT QA 
 
IMRT requires their dosimetric verification due to the complexity of the treatment 
plans. Therefore, before any IMRT treatment takes place, actual dose being delivered 
to the patient needs to be verified first [15].  The dose verification can be done using a 
phantom with calibrated system or films. There are various products that are 
commercially available today for IMRT verification such as flat-panel electronic portal 
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imaging devices (EPID) and ionisation chamber in the form of matrix or linear detector 
arrays.  A pre-treatment patient specific dose verification is done to check on the 
accuracy of dose calculation and delivery system.   
1.2.2 Dosimetric accuracy for IMRT verifications 
 
There is a need to validate individual IMRT treatment plans before the treatment is 
delivered on patients. This is due to the complexity of IMRT treatment that demands 
a stringent QA and accurate dose determination for delivery of highly conformal dose 
to the patients. Patient specific IMRT QA is performed by comparing the dose 
delivered to a dosimeter with the dose calculated by the TPS using the same treatment 
parameters [16]. The conventional method of performing pre-treatment patient 
specific dose verification is by using film [17,18].  For example, gafchromic film was 
normally used since it was the most cost-effective method and provided a good spatial 
resolution [19].  However, there were several problems when the film was being used 
for IMRT verification purpose as film requires 2D film density scanner to 
quantitatively convert optical density to dose [20].  Furthermore, film measurement 
involves difficult calibration [21]. Errors may be presented if the calibration process is 
not performed correctly. This calibration factor is important to ensure accurate 
conversion of the pixel values to the dose value. 
Apart from film, the electron portal imaging device (EPID) has good spatial 
resolution and can provide real-time measurements.  However, the sensitivity of EPID 
to MLC position error is low due to the imaging speed of EPID that is slow [22].  EPID 
response also changes with the cumulative exposure to radiation and requires frequent 
calibration [23]. The calibration algorithm requires noise correction to accurately 
convert the signal from EPID to dose [24].  
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In recent years, most clinics have been using a dosimetric phantom which is a 
detector array system in conjunction with solid water phantom.  The ionisation 
chamber array detector allows real-time measurements and have become the gold 
standard tool for patient specific QA in advanced radiotherapy.  The ionisation 
chamber array detector provides immediate results after beam delivery.  Although the 
resolution of ionisation chamber detector array is limited, it provides undeviating 
measurement of dose without frequent calibration. An example of the ionisation 
chamber array detector system is shown in Figure 1.6. 
 
Figure 1.6: Example of ion chamber detector array system. A PTW 2D Array 
Seven29 ion chamber (PTW, Freiburg, Germany) 
 
1.2.3 Method for patient specific IMRT QA for treatment verification 
 
The gamma analysis method is used as a routine QA procedure for dose verification 
in IMRT treatment. The method provides good quantitative index of any discrepancy 
of dose delivered compared to the dose planned. The gamma index method was 
proposed by Low et al. provides a comparison between the calculated dose from the 
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planning and the measured dose which is obtained from the measurement of detector 
used [25]. The examined parameters in gamma index includes the distance to 
agreement (DTA) and dose difference (DD). The gamma is defined as the square root 
of a linear quadratic addition of the two examined parameters; DTA and DD in relative 
magnitude to their acceptance criteria CDTA and CDD, as shown in Eq.1 
                       𝛾 =  √(
𝐷𝑇𝐴
𝐶𝐷𝑇𝐴
)
2
+  (
𝐷𝐷
𝐶𝐷𝐷
)
2
                                       (1) 
The gamma index technique calculates the quantity of gamma, γ, for each point 
of interest using preselected DD and DTA. Then, the γ value is used to determine the 
pass-fail of the IMRT QA. For example, if the spatial difference in the DTA and DD 
results within the clinical acceptance criteria of 3 mm and 3% respectively then the 
gamma index is ≤1, the criteria limits were not exceeded.  However, if it >1, the 
measurement result is outside the tolerance range. The percentage of points with γ 
value ≤1 is referred as gamma pass rate. 
1.3 Geometrical uncertainties in radiotherapy 
 
The highly conformal IMRT dose distributions are more sensitive to misalignments of 
the target with respect to the planned dose.  The geometrical uncertainties are the most 
common factor which may affect the accuracy and precision of radiotherapy 
treatments especially for IMRT as it creates more complex treatment in order to deliver 
higher dose to the target volume and reduce toxicities to normal tissues [26,27]. The 
geometrical uncertainties can occur in term of patient setup and organ motions.   
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1.3.1 Margin recipe 
 
The aim of radiotherapy treatments is to achieve high accuracy and precision of 
radiation delivery to the target. However, there are many sources of error that may 
occur during patient setup and treatment delivery that may affect the accuracy of 
radiotherapy treatment.  Therefore, a margin is essential to make sure that the planned 
dose is delivered to the target.  
There are various margin calculation methods proposed by researchers which 
are summarised in Table1.1. The margin in this study is determined using Van Herk 
formula based on measured systematic error, 𝛴,  and random error, 𝜎 , as shown in 
Table.1.1 [28].  The formula ensures 90% of studied patients receive a minimum 
cumulative CTV dose of at least 95% from the prescribed dose.  
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Table 1.1 Summary of published safety margin recipes for target (tumour) [29] 
Author  Margin recipe Assumptions 
Stroom et 
al.1999 
2 𝛴 + 0.7 𝜎                                           95% dose to an 
average 99% of 
CTV tested in 
realistic plans  
Van Herk et al. 
2000 
2.5 𝛴 + 0.7 𝜎                                         Minimumdose to 
CTV s 95% for 
90% of patients 
Mc Kenzie et al.  
2000 
2.5 𝛴 + 𝛽(𝜎 − 𝜎𝑝)                                           Extension of van 
Herk et al. for 
fringe dose due 
to limited 
number of beams 
 
 
1.3.2 Image guided radiotherapy (IGRT) 
 
Many technological inventions nowadays have resulted in significant progresses in 
radiotherapy planning, delivery, and verification including the integration of image 
guided modalities in the delivery of radiotherapy treatment.  The IGRT can be defined 
as the use of frequent imaging in the treatment room immediately prior to beam 
delivery.  The development of IGRT enables imaging of the tumour and patient setup 
immediately before IMRT treatment is delivered.  
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The systematic errors and random errors which might occur before and during 
treatment delivery can be reduced using IGRT. For example, if a patient is positioned 
incorrectly on the couch, a suitable correction was made to the couch position such 
that the patient can be treated according to the setup during treatment planning. 
However, if improper corrections were applied, there is a risk of missing the target 
volume. Missing the target during radiotherapy will resulted tumour underdose which 
may potentially increase the dose to surrounding normal tissues.  
IGRT uses CBCT to adjust target motion and positional uncertainties. A study 
has been done on impact of IGRT on radiotherapy treatment workflow and the result 
showed that 95% out of 601 respondents of American Society of Radiation Oncology 
(ASTRO) reported the high prevalence of IGRT over other portal imaging [30]. 
IGRT also helps in reducing the PTV margin which allow possible dose 
escalation to tumour volume and enables surrounding healthy tissue to be spared 
[26,27,31]. From the study done by Chen et al. he proved that PTV margin can be 
safely reduced for HNC patients from 5 mm to 3 mm with no differences in 
locoregional control and distant metasis-free survival using IGRT [32]. Den et al. has 
also proved that a 50% reduction in PTV margin for HNC patients could be achieved 
by demonstrating daily IGRT in IMRT treatments [33]. Thus, utilisation of IGRT 
during IMRT which is also known as IG-IMRT may help in reducing the risk of setup 
miss on HNC patients and treatment delivery of IMRT can further be improved with 
guidance from IGRT for a higher precision in beam delivery. 
1.3.2 (a) Cone-beam computed tomography (CBCT) 
 
Cone beam CT (CBCT) is an effective IGRT tool for the verification of patient 
position. The tomographic slices from a patient are obtained through the kV 
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source/imager that are placed on the rotating linac gantry [34]. The volumetric data set 
in one gantry rotation is enabled with the usage of kV cone-beam.  
The images from CBCT-based IGRT provide the setup errors of each patient 
and can be used to calculate the systematic and random error of the setup, and 
subsequently the PTV margin for patients with similar treatment setup. Example of 
gantry-mounted cone beam devices commercially available are the Elekta XVI (Elekta 
Medical Systems, Stockholm, Sweden) and Varian On Board Imager (OBI) (Varian 
Medical Systems, USA). X-ray source is one of the hardware components in CBCT.  
The x-ray source can either be in kV or MV. Each CBCT design has different target 
angle, travel range of the collimator and the focal spot values [35].  For example, the 
source of Elekta kV is a fan-cooled x-ray tube whereby the Varian OBI has an oil-
cooled rotating anode x-ray tube. Other than x-ray source, flat-panel imager (FPI) is 
also a hardware component in CBCT. The FPI technology is based on the 2D matrix 
of amorphous silicon (a-Si) thin-film transistors (TFTs) on a scintillating material 
(Thallium doped Caesium Iodide) [36]. The scintillator is used for converting x-ray 
photons into light photons for the a-Si TFTs to convert to electrical signals and readout 
as digital signal.  The projections of CBCT use the Feldkamp, Davis and Kress (FDK) 
algorithm. The measured cone-beam projections are pre-weighted, filtered and finally 
back projected along the same ray geometry used for forward projection [37]. 
1.3.2 (b) Correction strategies with image guided radiotherapy (IGRT) 
 
The correction strategies using IGRT are classified into online correction and offline 
correction. The online protocol compares the reference images from CT simulation 
with images from IGRT system taken in treatment delivery room. The protocol 
involves daily CBCT imaging and daily setup correction. The protocol measures the 
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difference as setup error and enables correction of the setup error for that treatment if 
it exceeds a designated threshold. This requires imaging, analysis and set-up correction 
before each fraction. A study done by Wang et al. showed that online correction can 
be effective at 2 mm threshold level [12].  
On the other hand, offline protocol acquired images before treatment and 
matched to the reference image after the treatment is delivered. The CBCT image 
acquired on that day will be reviewed offline and the correction will be done for future 
fraction. This protocol aims to determine the individual systematic setup error, thus 
reduce it. Widely used offline correction protocols include No Action Level (NAL) 
and extended No Action Level (eNAL) protocols [38].  Even with the limited number 
of CBCT images, these correction protocols are able to reduce the systematic setup 
error which plays the biggest impact on the PTV margin.   
 Previous study related to offline IGRT protocol showed that the protocol helps 
in reducing systematic error. For example, de Boer et al. investigated the performance 
using Monte Carlo and compare the effect of eNAL in reducing systematic setup error 
between different natures of population; no transitions, large linear transitions and 
frequent large transitions [39]. From the study, they found out offline IGRT technique; 
eNAL protocol reduces the systematic error irrespective of time-dependent changes 
that may occur in population. Other study performed by Martens et al. also showed 
the ability of offline IGRT protocol in reducing systematic error. However, their study 
focused on rotational setup error instead of translation setup error [40].   
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1.4 Dosimetric impact of geometrical uncertainties on dose 
distributions 
 
Geometrical uncertainties in radiotherapy can cause a deviation between the calculated 
dose from TPS and the actual delivered dose distribution. As mentioned in section 1.3, 
the uncertainties mainly consist of patient setup error and internal organ motion.  
The setup errors consist of systematic and random errors. Random errors may 
result in distorting the dose distribution. However, the impact on doses to the tumour 
and surrounding normal tissues is insignificant. This contradicts to the impact of 
systematic errors which may under dose or overdose both the tumour and normal 
tissues.  
Therefore, this study also aims to analyse the impact of 2D translational setup 
errors in right-left (RL) and superior-inferior (SI) directions, if not corrected towards 
dose distribution. The setup error in anterior-posterior (AP) direction was not included 
in the analysis as the verification of IMRT was performed on ionisation chamber array 
detector (PTW, Freiburg, Germany). The acceptation of the treatment planning was 
also performed based on 2D analysis using gamma index and Dose-Volume 
Histogram. 
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1.5 Purpose of study 
 
The main objective of the study is to investigate the accuracy of treatment using IG-
IMRT on head and neck cancer patients. Three sub-objectives are as follows. 
• To assess the dosimetric accuracy of IMRT treatment using ionisation chamber 
array detector (PTW, Freiburg, Germany) 
• To study the impact of geometrical accuracy on the delivered clinical IMRT 
treatments using IGRT 
• To study the effect of geometrical uncertainties on dose distributions 
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CHAPTER 2 MATERIALS AND METHODS 
 
2.1  Radiotherapy and dosimetry system 
 
This section describes the radiotherapy linac and treatment planning system (TPS) 
used to plan and deliver IMRT treatment in this study, followed by the dosimetry 
system used for the patient specific IMRT QA prior to treatment. This section also 
describes the characterisation of the dosimetry system used for the patient specific QA. 
The result of the dose measured from the dosimetry system will be compared with the 
dose calculated from the TPS. It is important to perform the characterisation to ensure 
that the detector is functioning well as this detector will be used for patient specific 
pre-treatment QA. The detector has to be able to measure the dose accurately since it 
affect the accuracy and precision of the dose measured for the IMRT patient. 
2.1.1 Radiotherapy linac and quality assurance 
 
Radiotherapy beam was delivered from Elekta linac (Elekta Medical System, 
Stockholm, Sweden). The linac delivered 6 MV photon beam and was equipped with 
160 Agility MLCs (Elekta Medical System, Stockholm, Sweden). The MLCs are 
arranged into two MLC banks, with each bank consist of 80 MLCs.  The right and left 
MLC bank are termed as Y1 and Y2 respectively.  
The CBCT mounted to the Elekta linac is called X-ray Volume Imaging (XVI). 
The XVI acquires and reconstructs the 3D image data simultaneously. Figure 2.1 
shows the user interface to compare the acquired CBCT images from the patient setup 
with the reference image from CT scan during treatment planning [26]. The x (RL 
direction), y (SI direction), and z (AP direction) axis displacements are then corrected 
by moving the couch on which the patient is immobilised. 
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Figure 2.1: X-ray volume imaging (XVI) software 
QA of the linac is important to ensure the accuracy of the radiation delivered 
from the machine. QA programme implemented for the linac has been adapted from 
the American Association of Physicists in Medicine Task Group (AAPM TG) number 
142 [41]. The QA procedures included daily, weekly, monthly, and yearly QA test. 
The QA programme for the linac aims to assure that the calibration and baseline values 
acquired at the time of acceptance and commissioning with the machine characteristics 
do not deviate significantly.  
The accuracy of IMRT treatment would be mainly affected by the linac dose 
output constancy. The dose output of the linac was checked daily using a Quickcheck 
device (PTW, Freiburg, Germany) that is an ionisation chamber cross calibrated with 
farmer ionisation chamber used to calibrate the linac.  
The mechanical QA tests such as gantry/collimator angle indicators and 
localising laser were also performed to guarantee the mechanical accuracy of IMRT 
treatment.  
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Other than dose output constancy and mechanical performance, the MLC 
performance also play an important role to ensure the accuracy of IMRT delivery. For 
MLC QA, the picket fence leaf pattern was used. For this QA procedure, the 
measurements were performed at fixed gantry angle and a slit of 2 cm × 20 cm 
dimensions stopping every 2 cm were used to produce seven pickets.   
Next, the accuracy of IGRT registration is also important in this study. Thus, 
the QA test aspect for IGRT system was also performed. The QA test was carried out 
by checking the accuracy of kV and MV CBCT registration.  
2.1.2 Treatment planning system (TPS) 
 
The TPS used throughout this study was Monaco treatment planning system (Elekta 
Medical System, Stockholm, Sweden). Monaco TPS uses Monte Carlo algorithm for 
dose calculation and optimisation of IMRT plans.  
2.1.3 Radiation detector for IMRT verification 
 
Ionisation chamber is considered the gold standard because of their precision, 
availability, and relative ease of use [42].  Therefore, the radiation detector used in this 
study was a matrix of 27 × 27 ionisation chambers known as the 2D array seven29 
detector (PTW, Freiburg, Germany). The detector consists of 729 ionisation chambers 
vented in a polymethyl methacrylate (PMMA) slab. Each cubic chamber has a size of 
0.5 × 0.5 × 0.5 cm3, with a center-to-center spacing between 2 adjacent chambers of 1 
cm, yielding a maximum field of 27 cm × 27 cm.  Throughout the study, the PTW 2D 
array seven29 ion chamber will be referred as ionisation chamber array detector.  
The Octavius phantom (PTW, Freiburg, Germany) is used with the ionisation 
chamber array detector to allow data acquisition from IMRT treatment.  The phantom 
cross section has an octagonal shape. The shape is designed to tolerate a complex 
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rotational IMRT plan verification.  The phantom is made of polystyrene with a 
physical density of 1.04 g/cm3. The phantom has a 30.0 × 30.0 × 2.2 cm3 central cavity 
for insertion of the ionisation chamber into the phantom.   
The Octavius phantom with ionisation chamber array detector was scanned 
using CT scanner and the images were exported into TPS. The CT scan images of both 
phantom and detector shown in Figure 2.2 will then be used in TPS for characterisation 
experiment and patient specific pre-treatment QA verification purposes.  
         
(a)                                                            (b) 
Figure 2.2: CT scan images of the phantom and detector from TPS (a) 
transverse plane (b) median plane 
 
 
 
2.1.4 Characterisation of the ionisation chamber array detector 
 
There is a need to submit the ionisation chamber array detector to various tests in order 
to verify its level of reliability.  Characterisation in term of dose rate dependency, 
linearity, reproducibility, SSD dependency, directional dependency and output factor 
will be studied comprehensively. 
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Before all the characterisation experiments were performed, the ionisation 
chamber array detector was inserted into the Octavius linac phantom as seen in Figure 
2.3.  The RS232 cable was connected to the PTW array interface before the PTW array 
interface was switched on. The cable transfers the measurements obtained on the 2D 
array to a computer with data acquisition software, Verisoft (PTW, Freiburg, 
Germany).  
For characterisation of ionisation chamber array purpose, the measured dose 
from ionisation chamber array detector will be compared with dose calculated using 
TPS. Therefore, firstly, the scanned images shown in Figure 2.2 were imported into 
TPS. Then, the central ionisation chamber was contoured on the scanned image using 
TPS. All the treatment parameters that will be used for each characterisation 
experiments which will be described in Section 2.1.4(a)-(f) were planned on the TPS 
system and the resulted dose was calculated. The dose output calculated from the TPS 
was recorded and compared with the dose measured from the detetcor.  
The phantom was setup perpendicularly to the in-room laser as shown in Figure 
2.4. The gantry and collimator angles were also set to 0⁰. The SSD was kept at 84 cm. 
Then, the ionisation chamber array detector with Octavius phantom was calibrated 
using a cross-calibration procedure to calculate a cross calibration factor. A 200 MU 
was delivered on 10 x10 cm2 field size with a dose rate of 600 MU/min.  This factor 
was then applied to the entire matrix.  
